Medication info
Hyushiglome Sustained Release Tablet 5/50/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Hyushiglome Sustained Release Tablet 5/50/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletDapagliflozin Propanediol Hydrate›6.15mg / 1 tabletSitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Pale yellow, bilaterally convex, oval sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202500711 · Approved 2025.03.27 · Insurance code 670609500

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily; patients taking it as 5/50/1000 mg extended-release tablets should take 2 tablets together once daily. The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. Patients with renal impairment require dose adjustment according to renal function; no dose adjustment is necessary for patients with mild renal impairment. If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or more and less than 60mL/min/1.73m2, the starting dose of metformin hydrochloride is 500mg or 750mg once daily, and the maximum daily dose is 1000mg. If the estimated glomerular filtration rate is less than 45mL/min/1.73m2, discontinue treatment immediately.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with diet and exercise therapy to help manage blood sugar levels in patients with type 2 diabetes. It particularly aids in more effective blood sugar control when used in combination with dapagliflozin, sitagliptin, and metformin, thereby contributing to the health improvement of those who struggle with blood sugar management.

How to take

Adult dose

To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening. Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily; patients taking it as 5/50/1000 mg extended-release tablets should take 2 tablets together once daily. The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg. Patients with renal impairment require dose adjustment according to renal function; no dose adjustment is necessary for patients with mild renal impairment. If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or more and less than 60mL/min/1.73m2, the starting dose of metformin hydrochloride is 500mg or 750mg once daily, and the maximum daily dose is 1000mg. If the estimated glomerular filtration rate is less than 45mL/min/1.73m2, discontinue treatment immediately.

Precautions

This medication contains a mixture of ingredients used in the treatment of diabetes. First, the sitagliptin component may rarely cause serious allergic reactions. Such reactions can occur within three months of starting the medication, so if symptoms like skin rash or difficulty breathing develop, it is essential to stop taking the medication immediately and consult a doctor. Moreover, sitagliptin poses a risk of acute inflammation of the pancreas (acute pancreatitis), so if abdominal pain, nausea, or vomiting occur during treatment, medical personnel must be informed immediately. The metformin ingredient may rarely lead to a severe metabolic disorder known as lactic acidosis. This condition can cause symptoms such as vomiting, abdominal pain, muscle pain, difficulty breathing, and lethargy, and immediate medical attention should be sought if it occurs. This medication is not to be administered to patients with moderate to severe renal impairment, dehydration, severe infection, heart failure, acute myocardial infarction, or other kidney or heart-related issues. Moreover, this medication must be discontinued before examinations involving radiological iodinated contrast agents, and it can only be resumed after confirming normal kidney function post-examination. Patients who are pregnant or who have severely impaired liver function should also not use this medication. During treatment with this medication, side effects such as hypoglycemia, fluid loss, urinary and genital infections may occur; if symptoms arise, immediate consultation with a physician is necessary. In particular, patients with reduced fluid volume or low blood pressure, elderly individuals, and those with decreased kidney function should take extra caution and undergo regular kidney function tests. This medication can induce a severe metabolic complication known as diabetic ketoacidosis, so if symptoms of ketoacidosis appear even when blood sugar levels are not elevated, immediate treatment should be sought. Finally, alcohol consumption should be avoided while taking this medication, and if symptoms of dehydration or severe gastrointestinal disturbances occur, the medication should be discontinued and a doctor consulted.

Side effects

  • Hypersensitivity
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disorders
  • acute pancreatitis
  • lactic acidosis
  • hypoglycemia
  • genital infections
  • vulvitis
Show 99 more
  • balanitis
  • fungal infections
  • perineal necrosis
  • reduced fluid volume
  • thirst
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • elevated hematocrit
  • increased blood creatinine
  • dyslipidemia
  • urinary tract infection
  • decreased renal creatinine clearance
  • acute kidney failure
  • rash
  • urticaria
  • cutaneous vasculitis
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • gastroesophageal reflux disease
  • upper abdominal pain
  • diverticulum
  • intestinal perforation
  • chronic pancreatitis
  • hyperglycemia
  • paresthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • diverticulitis
  • pelvic inflammatory disease
  • pneumonia
  • pulmonary tuberculosis
  • weakness
  • pain
  • ligament sprain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • bile duct stones
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • acute pyelonephritis
  • chest pain
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • urinary retention
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • decreased appetite
  • headache
  • nasopharyngitis
  • chest discomfort
  • peripheral edema
  • generalized edema
  • hunger
  • vaginal discharge
  • menstrual irregularities
  • itching
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyps
  • tinnitus
  • taste impairment
  • erythema
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow, bilaterally convex, oval sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.